5-oxo-prolyl-glycyl-arginine-4-nitroanilide and Glioma

5-oxo-prolyl-glycyl-arginine-4-nitroanilide has been researched along with Glioma in 2 studies

*Glioma: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21) [MeSH]

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Noha, M; Takahashi, H; Teramoto, A; Watanabe, K; Yoshida, D	1
Hamasuna, R; Iseda, T; Kataoka, H; Koono, M; Moriyama, T; Nakano, S; Sameshima, T; Wakisaka, S; Yokogami, K; Yoshida, E	1

Other Studies

2 other study(ies) available for 5-oxo-prolyl-glycyl-arginine-4-nitroanilide and Glioma

Article	Year
Suppression of matrix metalloproteinase activity by SI-27: detection by a new activity assay with S-2444, a specific chromogenic peptide. Journal of neuro-oncology, 2002, Volume: 58, Issue:1 Topics: Chromogenic Compounds; Collagen; Dose-Response Relationship, Drug; Glioma; Humans; Isoenzymes; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Oligopeptides; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2; Tumor Cells, Cultured	2002
Simultaneous up-regulation of urokinase-type plasminogen activator (uPA) and uPA receptor by hepatocyte growth factor/scatter factor in human glioma cells. Clinical & experimental metastasis, 1999, Volume: 17, Issue:10 Topics: Central Nervous System Neoplasms; Glioma; Hepatocyte Growth Factor; Humans; Oligopeptides; Proto-Oncogene Proteins c-met; Receptors, Cell Surface; Receptors, Urokinase Plasminogen Activator; Tumor Cells, Cultured; Up-Regulation; Urokinase-Type Plasminogen Activator	1999

Article

Year

Suppression of matrix metalloproteinase activity by SI-27: detection by a new activity assay with S-2444, a specific chromogenic peptide.

Journal of neuro-oncology, 2002, Volume: 58, Issue:1

Topics: Chromogenic Compounds; Collagen; Dose-Response Relationship, Drug; Glioma; Humans; Isoenzymes; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Oligopeptides; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2; Tumor Cells, Cultured

2002

Simultaneous up-regulation of urokinase-type plasminogen activator (uPA) and uPA receptor by hepatocyte growth factor/scatter factor in human glioma cells.

Clinical & experimental metastasis, 1999, Volume: 17, Issue:10

Topics: Central Nervous System Neoplasms; Glioma; Hepatocyte Growth Factor; Humans; Oligopeptides; Proto-Oncogene Proteins c-met; Receptors, Cell Surface; Receptors, Urokinase Plasminogen Activator; Tumor Cells, Cultured; Up-Regulation; Urokinase-Type Plasminogen Activator

1999